about
Evidence for chronic low-grade systemic inflammation in individuals with agoraphobia from a population-based prospective studyAdipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.Associations of serum uric acid and SLC2A9 variant with depressive and anxiety disorders: a population-based study.Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population.Atypical depression and alcohol misuse are related to the cardiovascular risk in the general population.Determinants of the development of post-traumatic stress disorder, in the general population.Tracing the associations between sex, the atypical and the combined atypical-melancholic depression subtypes: A path analysis.Aspirin and statin use and the subsequent development of depression in men and women: Results from a longitudinal population-based study.Clinical and course characteristics of depression and all-cause mortality: A prospective population-based study.Individuals' quality of life linked to major life events, perceived social support, and personality traits.Inter-informant agreement and prevalence estimates for mood syndromes: direct interview vs. family history method.The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: Results from a large longitudinal population-based study.Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study.Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study.Association of serum homocysteine with major depressive disorder: results from a large population-based study.Years of life lost due to the psychosocial consequences of COVID19 mitigation strategies based on Swiss dataYears of life lost due to the psychosocial consequences of COVID19 mitigation strategies based on Swiss data
P50
Q28546156-63C4CE18-62AE-4808-806E-02E2253F129BQ34517195-83636A76-6D59-411A-A7AF-B359D2AF5F4BQ35034635-5A179F01-B5A7-4360-AA1F-9B7FA082A57AQ39304122-68169E14-F833-456B-8048-8DCAD7EC99B6Q40078755-026CBE0C-384A-4C6D-8F64-B4037F6BA1BCQ40136233-10BEB847-FCE7-4ED3-9A93-BE91FA953265Q40254934-61CE2256-9937-48AF-A08C-8B7CCF56B8B7Q40281365-6DDDEF31-397E-498A-A30E-89B6C0CE34CFQ40316464-46C07FF3-0F26-43F7-BE3A-8FCD7542A2C8Q40789335-D867B0F6-EE9A-42EA-9C72-1DAA5FCA96B1Q44213288-362B7D35-CD3A-4557-BADB-72567F5CD6B1Q47289784-CF039240-1A3F-4E90-8370-671BC8ADFEA3Q48240637-041CF6A7-83DC-4567-BD47-5F8107560470Q48280429-9BDAD6DC-CBB5-4EE4-8276-E74BA9DAB7D7Q48470197-C83EBB7C-7E94-4EEF-AF48-994D1DCCE501Q95627992-087C4048-07EA-4CEC-B3F0-A67E05E3AB57Q95933514-CFA52B8E-C567-4421-9F89-EA3ED32AA5BD
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
J Glaus
@ast
J Glaus
@en
J Glaus
@es
J Glaus
@nl
type
label
J Glaus
@ast
J Glaus
@en
J Glaus
@es
J Glaus
@nl
prefLabel
J Glaus
@ast
J Glaus
@en
J Glaus
@es
J Glaus
@nl
P106
P31
P496
0000-0001-8883-9473